Importance of World Glaucoma Day

Article

Your thoughts on the efficacy of initiatives such as World Glaucoma Day.

Key Points

World Glaucoma Day on March 12th saw huge participation amongst the ophthalmology community across both Europe and the rest of the world and the message from its organisers was clear - the role of the clinician in the early detection of glaucoma cannot be overemphasized. But what did you think?

"Glaucoma is a slowly progressive degeneration of the optic nerves. It is often (but not always) associated with elevated IOP. The vision loss in glaucoma occurs first in the periphery before involving the central vision. Patients are, therefore, unaware of the progressive loss of peripheral vision until the very advanced stages of the disease," said Dr. Ritchie, co-chairman of the World Glaucoma Day Committee of the World Glaucoma Association.

Effective screening for glaucoma includes some additional tests. "Of course, no examination is complete without darkroom gonioscopy to identify angle closure, IOP measurement, and examination of the optic nerves for disc haemorrhage, parapapillary atrophy, nerve fibre layer defects, and the appearance of the neuroretinal rim. Patients with risk factors for glaucoma or a suggestive clinical examination may then undergo the appropriate perimetric testing and imaging of the optic nerve head to assess the extent of disease. Stereoscopic disc photography in patients with glaucoma risk factors is a powerful tool to establish a baseline and detect future pre-perimetric glaucomatous change," noted Dr. Angelilli, a clinical instructor at the New York University Medical Centre.

If you are not already a member of the European ophthalmology community go to http://www.oteurope.com/forum/ or pose your questions to colleagues at http://www.oteurope.com/discuss/

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.